The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. C, 1999, Pages 1-3

  Keller, N ^a   Smollen, G ^a   Davidson, Y ^a   Barzilai, A ^a   Keren, G ^a   Rubinstein, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFUROXIME; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CONFERENCE PAPER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 0032973454     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. File, T. M. & Tan, J. S. (1997). Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia. Current Opinion in Pulmonary Medicine 3, 89-97.
2. Zenni, M. K., Cheatham, S. H., Thompson, J. M., Reed, G. W., Batson, A. B., Palmer, P. S. et al. (1995). Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. Journal of Pediatrics 127, 533-7.
3. Faden, H., Duffy, L., Wasielewski, R., Wolf, J., Krystofik, D. & Tung, Y. (1997). Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/ Williamsville Pediatrics. Journal of Infectious Diseases 175, 1440-5.
4. Brooks, G. F., Butel, J. S. & Ornston, L. N. (1995). Antimicrobial chemotherapy. In Medical Microbiology, 20th edn, (Brooks, G. F., Butel, J. S. & Ornston, L. N., Eds), pp. 137-66. Prentice Hall, London.
5. Hansman, D., Devitt, L., Miles, H. & Riley, I. (1974). Pneumococci relatively insensitive to penicillin in Australia and New Guinea. Medical Journal of Australia ii, 353-6.
6. Goldstein, F. W., Acar, J. F. & the Alexander Project Collaborative Group. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. Antimicrobial Agents and Chemotherapy 38, Suppl. A, 71-84.
7. Goldstein, F. W. & Garau, J. (1997). 30 years of penicillin-resistant S. pneumoniae: myth or reality? Lancet 350, 233-4.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition: Approved Standard M7-A3. NCCLS, Wayne, PA.
9. Dark, D. S., Farber, M., Rice, K., Levin, D., Merrill, W., Mufson, M. et al. (1995). Oral ofloxacin versus cefaclor for LRTIs in adults. Infections in Medicine 12, 551-6.
10. Kahn, J. B. (1996). Assessment of ofloxacin for community acquired LRTIs. Infections in Medicine 13, 141-51.
11. George, J. & Morrissey, I. (1997). The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 39, 719-23.
12. Martin, S. J., Meyer, J. M., Chuck, S. K., Jung, R., Messick, C. R. & Pendland, S. L. (1998). Levofloxacin and sparfloxacin: new quinolone antibiotics. Annals of Pharmacotherapy 32, 320-36.
13. Thomson, K. S., Chartrand, S. A., Sanders, C. C. & Block, S. L (1997). Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 478-80.
14. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP 99,219, compared with DU6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and penicillin-resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
15. De Abate, C. A., Russell, M., McElvaine, P., Faris, H., Upchurch, J., Fowler, C. L. et al. (1997). Safety and efficacy of oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbation of chronic bronchitis. Respiratory Care 42, 206-13.
16. File, T. M., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R. R. et al. (1997). A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy 41, 1965-72.
17. Sydnor, A., Kopp, E. J., Anthony, K. & Fowler, C. L. (1997). A multicenter, noncomparative study to evaluate the safety and efficacy of oral levofloxacin (LVFX) in the treatment of acute sinusitis in adults. Journal of Allergy and Clinical Immunology 78, 125.
18. Portier, H., May, T., Proust, A. & The French Study Group. (1996). Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 83-91.
19. Goa, K. L., Bryson, H. M. & Markham, A. (1997). Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections. Drugs 53, 700-25.